Back to search results

Tailored Patient Navigation for Lung Cancer Screening in Tribal Communities

This study, called SACRED LUNGS, is looking at whether personalized support, called patient navigation (PN), can help more people in tribal communities in Western Washington State get screened for lung cancer. Lung cancer screening (LCS) uses a special X-ray called a chest computed tomography (CT) scan to find lung cancer early. This study compares receiving tailored PN activities to receiving an educational handout and discussing screening with your doctor. The main goal is to see if more people complete their chest CT scan within six months. You might be able to join if you are between 50 and 77 years old, have smoked for at least 20 pack-years, and have used commercial tobacco within the last 15 years. The current recruitment status is unclear.

Study design
This is an interventional study planning to enroll 237 participants. Participants will be randomly assigned to one of two groups.
What's involved
Participants in one group will receive tailored PN activities and an educational handout for 21 months. The other group will receive an educational handout and discuss LCS with their doctor for 6 months, then receive tailored PN for 15 months.
Compensation
Not stated in the trial record.
Follow-up
The primary goal of completing a chest CT scan is measured up to 6 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07176000

Tailored Patient Navigation to Improve the Uptake of Lung Cancer Screening in Tribal Communities in Western Washington State, SACRED LUNGS Trial

Recruiting
NAAges 18+InterventionalScreening
Fred Hutchinson Cancer Center
~237 participants
Updated 2026-08-25 on ClinicalTrials.gov
What's tested:Patient NavigationEducational InterventionBest PracticeInterviewSurvey AdministrationElectronic Health Record Review

At a glance

Recruiting sites
2 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Completion of chest computed tomography (CT) (Aim 1.2)
Measured over Up to 6 months

Conditions

Lung Carcinoma

Explore related trials

Lung Carcinoma

Where it's being run

2 sites across 1 states
Washington2

Study leadership

  • Matty Triplette, MD, MPH · PRINCIPAL_INVESTIGATOR · Fred Hutch/University of Washington Cancer Consortium

Who to contact

Matty Triplette, MD, MPH
[email protected]
(206) 667-6335
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

AIM 1.2 RANDOMIZED CONTROLLED TRIAL: Between ages 50-77
AIM 1.2 RANDOMIZED CONTROLLED TRIAL: Self-reported 20-pack year smoking history
AIM 1.2 RANDOMIZED CONTROLLED TRIAL: Ongoing commercial tobacco use within the past 15 years
AIM 1.2 RANDOMIZED CONTROLLED TRIAL: Seen by a PCP at a participating clinic (South Puget Intertribal Planning Agency \[SPIPA\] or Muckleshoot) within the past three years
Potential participants who want to establish care at an eligible clinic will be connected to a PCP
AIM 2 CLINICAL STAFF SURVEYS AND SEMI-STRUCTURED INTERVIEWS: At least 18 years of age
AIM 2 CLINICAL STAFF SURVEYS AND SEMI-STRUCTURED INTERVIEWS: Affiliation with Muckleshoot or SPIPA (one of the 6 community partnering clinics) as a provider, or supportive staff member
AIM 2 PATIENT SURVEYS AND SEMI-STRUCTURED INTERVIEWS: Patient participated in the aim 1.2 trial
AIM 3 CLINICAL STAFF SURVEYS AND SEMI-STRUCTURED INTERVIEWS: At least 18 years of age
AIM 3 CLINICAL STAFF SURVEYS AND SEMI-STRUCTURED INTERVIEWS: Affiliation with Muckleshoot or SPIPA (one of the 6 community partnering clinics) as a provider, or supportive staff member
AIM 3 PATIENT SURVEYS AND SEMI-STRUCTURED INTERVIEWS: Patient participated in the aim 1.2 trial

Exclusion

AIM 1.2 RANDOMIZED CONTROLLED TRIAL: Has had a documented chest CT within the past one year
AIM 1.2 RANDOMIZED CONTROLLED TRIAL: Personal history of lung cancer
AIM 1.2 RANDOMIZED CONTROLLED TRIAL: Personal history of any cancer within 5 years except for basal cell or squamous cell skin carcinoma

What this trial measures

  • Completion of chest computed tomography (CT) (Aim 1.2)Up to 6 months

    Will be compared between arms using the Cochran-Mantel-Haenszel (CMH) test, accounting for the stratification variables used during randomization. Completion rates will also be estimated in each arm and 95% confidence intervals for the rates and their difference will be calculated using Wilson's score method. The single primary outcome will be tested using two-sided α = 0.05.